Related Experiment Video
Updated: Dec 19, 2025

Development of Compendium for Esophageal Squamous Cell Carcinoma
Published on: April 12, 2024
Expression of lncRNA AK058003 in esophageal carcinoma and analysis of its intervention effect
1Department of Cardiothoracic Surgery, Tianjin Medical University General Hospital, Tianjin, China. pengzhang01@tmu.edu.cn.
Objective:
The aim of this study was to investigate the expression of long non-coding ribonucleic acid (lncRNA) AK058003 in esophageal carcinoma (EC) tissues, and to analyze its intervention effect.
Patients And Methods:
The expression of lncRNA AK058003 in EC tissues and para-carcinoma tissues from 130 EC patients was detected via quantitative Polymerase Chain Reaction (qPCR). EC cell lines were selected for exogenous interference in lncRNA AK058003. Subsequently, the expression of lncRNA AK058003 in normal esophageal epithelial cell line (Het-1A) and EC cell lines (EC109, EC9706, KYSE-150, KYSE-30, and TE-1) was detected by qPCR. EC9706 cell lines with the highest expression of lncRNA AK058003 were selected and transfected with lncRNA AK058003 siRNA and lncRNA AK058003 control, respectively. After transfection, the expression of lncRNA AK058003 was determined using PCR. The changes in cell growth and proliferation were analyzed via cell growth curve and cell cycle assay. Meanwhile, the changes in cell migration and invasion were analyzed through wound healing assay. Protein expressions of matrix metalloproteinase-1 (MMP1) and MMP2 were determined by Western blot. Clinical data were collected from EC patients, and the association between lncRNA AK058003 expression and tumor-node-metastasis (TNM) stage was finally analyzed.
Results:
LncRNA AK058003 was highly expressed EC tissues compared with para-carcinoma tissues (p<0.01). Compared with Het-1A cells, the expression of lncRNA AK058003 was significantly higher in EC109, EC9706, KYSE-150, KYSE-30, and TE-1 cells, with highest level in EC9706 cells (p<0.05). The expression of lncRNA AK058003 remarkably declined in lncRNA AK058003 siRNA group compared with lncRNA AK058003 control group (p<0.001). Compared with lncRNA AK058003 control group, the proliferation of EC cells was significantly weakened in lncRNA AK058003 siRNA group, with the greatest difference at 3 d. Flow cytometry results revealed that cell cycle was arrested in G0/G1 phase in lncRNA AK058003 siRNA group. Wound healing assay indicated that the intercellular distance became large, and cell migration ability was evidently enhanced in lncRNA AK058003 siRNA group with time (p<0.05). Besides, the protein expressions of MMP1 and MMP2 were remarkably lower in lncRNA AK058003 siRNA group than those in lncRNA AK058003 control group. This indicated remarkably declined invasion and metastasis ability. In addition, the postoperative prognosis was significantly worse in patients with higher expression of lncRNA AK058003 (p<0.05). All these findings suggested that lncRNA AK058003 could serve as a biomarker for EC prognosis.
Conclusions:
LncRNA AK058003 is highly expressed in EC patients, which promotes proliferation, migration, invasion, and metastasis of EC cells. In addition, the postoperative prognosis of EC patients with high expression of lncRNA AK058003 is relatively poor.
Insights
Long non-coding RNA (lncRNA) AK058003 is highly expressed in esophageal carcinoma (EC) tissues, promoting cancer cell proliferation and metastasis. High lncRNA AK058003 expression correlates with poorer patient prognosis, suggesting its potential as a diagnostic biomarker.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Esophageal carcinoma (EC) is a significant global health concern.
- The role of long non-coding RNAs (lncRNAs) in cancer development is increasingly recognized.
- Identifying novel biomarkers for EC diagnosis and prognosis is crucial.
Purpose of the Study:
- To investigate the expression levels of lncRNA AK058003 in EC tissues.
- To analyze the functional role of lncRNA AK058003 in EC cell proliferation, migration, and invasion.
- To evaluate the potential of lncRNA AK058003 as a prognostic biomarker for EC.
Main Methods:
- Quantitative Polymerase Chain Reaction (qPCR) to detect lncRNA AK058003 expression in patient tissues and cell lines.
- Exogenous interference using lncRNA AK058003 siRNA in EC cell lines.
- Cell proliferation assays (cell growth curve, cell cycle analysis).
- Cell migration and invasion assays (wound healing assay).
- Western blot analysis for matrix metalloproteinase (MMP) protein expression.
- Correlation analysis between lncRNA AK058003 expression and clinical parameters (TNM stage).
Main Results:
- lncRNA AK058003 was significantly upregulated in EC tissues compared to adjacent non-cancerous tissues.
- Higher expression of lncRNA AK058003 was observed in EC cell lines versus normal esophageal epithelial cells.
- Silencing lncRNA AK058003 with siRNA significantly inhibited EC cell proliferation, induced G0/G1 cell cycle arrest, and reduced cell migration and invasion.
- Downregulation of MMP1 and MMP2 protein expression was observed after lncRNA AK058003 silencing.
- High lncRNA AK058003 expression was associated with a worse postoperative prognosis in EC patients.
Conclusions:
- lncRNA AK058003 is oncogenic in esophageal carcinoma, promoting tumor growth and metastasis.
- lncRNA AK058003 plays a critical role in regulating cell cycle, proliferation, migration, and invasion.
- lncRNA AK058003 serves as a potential prognostic biomarker for esophageal carcinoma.
Related Concept Videos
lncRNA - Long Non-coding RNAs
lncRNA - Long Non-coding RNAs
Non-LTR Retrotransposons
